Evidence map›Paper›PMID 31729774›Full record

ArticlePhotochemistry and photobiology2020

Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.

Yi Hong Ong, Andreaa Dimofte, Michele M Kim, Jarod C Finlay, Tianqi Sheng, Sunil Singhal, Keith A Cengel, Arjun G Yodh, Theresa M Busch, Timothy C Zhu

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Light Fluence Rate and Tissue Oxygenation (SPhotochemistry and photobiology · 2020
    Article
  11. Article
  12. PDT Light Fluence Phantom Modeling of the Human Pleural Cavity: A Proof-of-Concept Pre-Clinical Study.Proceedings of SPIE--the International Society for Optical Engineering
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yi Hong OngDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-2826-1451
Andreaa DimofteDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Michele M KimDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Jarod C FinlayDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Tianqi ShengDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Sunil SinghalDivision of Thoracic Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Keith A CengelDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Arjun G YodhDepartment of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA.
Theresa M BuschDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-5499-8377
Timothy C ZhuDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-2842-8984
University of Pennsylvania · US

Funding

TUMOR HYPOXIA, PHOTOSENSITIZER, VASCULARITY AND PDTP01CA087971 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BUSCH, THERESA M, CENGEL, KEITH A · 2001 to 2019
$24.8M
Training and DisseminationP41EB015893 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI REDDY, RAVINDER · 2012 to 2019
$11.3M
Diffuse Optics for Acute Stroke ManagementR01NS060653 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI YODH, ARJUN G. · 2008 to 2018
$5.5M
Photodynamic therapy with prior inhibition of epidermal growth factor receptor to stimulate antitumor innate immune responseR01CA236362 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BUSCH, THERESA M · 2019 to 2023
$2.2M
Image-guided treatment planning for pleural Photodynamic TherapyR01CA154562 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ZHU, TIMOTHY C. · 2012 to 2016
$1.6M
NCI NIH HHS P01 CA087971NCI NIH HHS R01 CA154562NCI NIH HHS R01 CA236362NIBIB NIH HHS P41 EB015893NIH HHS P01 CA087971NIH HHS P41 EB015893NIH HHS R01 CA154562NIH HHS R01 CA236362NIH HHS R01 NS060653NINDS NIH HHS R01 NS060653
6 · The paper itself

Abstract

Explicit dosimetry of treatment light fluence and implicit dosimetry of photosensitizer photobleaching are commonly used methods to guide dose delivery during clinical PDT. Tissue oxygen, however, is not routinely monitored intraoperatively even though it is one of the three major components of treatment. Quantitative information about in vivo tissue oxygenation during PDT is desirable, because it enables reactive oxygen species explicit dosimetry (ROSED) for prediction of treatment outcome based on PDT-induced changes in tumor oxygen level. Here, we demonstrate ROSED in a clinical setting, Photofrin-mediated pleural photodynamic therapy, by utilizing tumor blood flow information measured by diffuse correlation spectroscopy (DCS). A DCS contact probe was sutured to the pleural cavity wall after surgical resection of pleural mesothelioma tumor to monitor tissue blood flow (blood flow index) during intraoperative PDT treatment. Isotropic detectors were used to measure treatment light fluence and photosensitizer concentration. Blood-flow-derived tumor oxygen concentration, estimated by applying a preclinically determined conversion factor of 1.5 × 10

Indexed as

AnimalsDihematoporphyrin EtherHumansMicePhotochemotherapyPhotosensitizing AgentsPleural NeoplasmsReactive Oxygen SpeciesXenograft Model Antitumor AssaysDihematoporphyrin EtherPhotosensitizing AgentsReactive Oxygen Species

Identifiers

PMID31729774
PMCPMC7299188
OpenAlexW2965977334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.